BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
28 05 2019
Historique:
received: 19 09 2018
revised: 23 12 2018
accepted: 11 02 2019
pubmed: 25 2 2019
medline: 6 2 2020
entrez: 25 2 2019
Statut: ppublish

Résumé

This study investigated the prevalence of TIL subpopulations, TLS, PD-1 and PD-L1 in tumors from TNBC patients harboring wild-type or mutated BRCA1 or BRCA2 germline genes. This TNBC cohort included 85% TIL-positive (≥10%) tumors with 21% classified as TIL

Identifiants

pubmed: 30797818
pii: S0304-3835(19)30105-3
doi: 10.1016/j.canlet.2019.02.027
pii:
doi:

Substances chimiques

B7-H1 Antigen 0
CD274 protein, human 0
PDCD1 protein, human 0
Programmed Cell Death 1 Receptor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-97

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Cinzia Solinas (C)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: Cinzia.Solinas@bordet.be.

Diane Marcoux (D)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: Diane.Marcoux@bordet.be.

Soizic Garaud (S)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: soizic.garaud@bordet.be.

Joel Rodrigues Vitória (JR)

IRIBHM, Bioinformatics Laboratory, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: joerodri@ulb.ac.be.

Gert Van den Eynden (G)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus Campus, Wilrijk, Belgium. Electronic address: vandeneyndeng@hotmail.com.

Alexandre de Wind (A)

Department of Pathology, Institut Jules Bordet, Brussels, Belgium. Electronic address: roland.dewind@bordet.be.

Pushpamali De Silva (P)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: Pushpamali.DeSilva@bordet.be.

Anaïs Boisson (A)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: Anais.Boisson@bordet.be.

Ligia Craciun (L)

Department of Pathology, Institut Jules Bordet, Brussels, Belgium. Electronic address: ligia.craciun@bordet.be.

Denis Larsimont (D)

Department of Pathology, Institut Jules Bordet, Brussels, Belgium. Electronic address: denis.larsimont@bordet.be.

Martine Piccart-Gebhart (M)

Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be.

Vincent Detours (V)

IRIBHM, Bioinformatics Laboratory, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: vdetours@ulb.ac.be.

Daphné t'Kint de Roodenbeke (D)

Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: daphne.tkint@bordet.be.

Karen Willard-Gallo (K)

Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: karen.willard-gallo@bordet.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH